• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem Angina (1710)
Event Date 04/04/2022
Event Type  Injury  
Event Description
Agent ide study.It was reported that stable angina occurred.On (b)(6) 2021, multiple synergy drug eluting stents implanted in left main (lm), left anterior descending artery (lad) and left circumflex artery (lcx).The proximal circumflex artery (cx) was treated with balloon angioplasty and synergy drug eluting stent (des).On (b)(6) 2022, the subject presented with stable angina and was referred for the agent ide study.The 90% stenosed target lesion was located at proximal cx and was 10 mm long with a reference vessel diameter of 3.5 mm.The target lesion was predilated using 4.0 mm x 20 mm nc balloon and laser atherectomy with 30% residual stenosis and timi flow of 3.Following pre-dilation, the lesion was treated with 3.50 mm x 30 mm study device successfully with 30% residual stenosis and timi flow of 3.The non-target lesion was located at left main coronary artery (lmca) and was treated using 5.0 mm x 12 mm balloon successfully prior to target lesion treatment.The subject was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18332466
MDR Text Key330553649
Report Number2124215-2023-71246
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
Patient SexMale
Patient RaceBlack Or African American
-
-